We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

41 hedge funds and large institutions have $54.6M invested in Summit Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 8

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

27% more capital invested

Capital invested by funds: $42.9M → $54.6M (+$11.7M)

11% more funds holding

Funds holding: 37 → 41 (+4)

0.12% more ownership

Funds ownership: 11.09% → 11.21% (+0.12%)

Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
17
Reduced
8
Closed
6
Calls
$90K
Puts
–
Net Calls
+$90K
Net Calls Change
+$90K

Top Buyers

1
PCH
Polar Capital Holdings
United Kingdom
+$2.31M
2
Millennium Management
Millennium Management
New York
+$2.13M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$683K
4
Goldman Sachs
Goldman Sachs
New York
+$334K
5
LCS
Levin Capital Strategies
New York
+$216K

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$3.03M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.19M
3
ECM
ExodusPoint Capital Management
New York
-$596K
4
Morgan Stanley
Morgan Stanley
New York
-$251K
5
BP
BBR Partners
New York
-$235K
Name Holding Trade Value Shares
Change 		Change in
Stake
H
26
HoyleCohen
California
$61K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$28K +$6.67K +1,034 +27%
RE
28
RBC Europe
United Kingdom
$18.6K +$7.74K +1,200 +61%
SPIA
29
Steward Partners Investment Advisory
New York
$11.7K – – –
PCM
30
Penserra Capital Management
California
$11K -$839 -130 -6%
US Bancorp
31
US Bancorp
Minnesota
$10K +$10.2K +1,582 +732%
HI
32
Harbour Investments
Wisconsin
$8K +$8.39K +1,300 New
LC
33
Lindbrook Capital
California
$5K +$219 +34 +4%
S
34
SignatureFD
Georgia
$5K +$3.12K +483 +119%
CAM
35
Close Asset Management
United Kingdom
$5K +$5.16K +800 New
QCG
36
Quadrant Capital Group
Ohio
$3K +$1.33K +207 +58%
PA
37
Parallel Advisors
California
$2K +$968 +150 +61%
Daiwa Securities Group
38
Daiwa Securities Group
Japan
$1K – – –
BCPWM
39
Bradley & Co Private Wealth Management
Florida
$1K +$1.29K +200 New
BP
40
BBR Partners
New York
– -$235K -50,000 Closed
Capstone Investment Advisors
41
Capstone Investment Advisors
New York
– -$175K -37,238 Closed
Squarepoint
42
Squarepoint
New York
– -$60K -12,751 Closed
VF
43
Virtu Financial
New York
– -$51K -10,835 Closed
ASN
44
Advisory Services Network
Georgia
– -$3K -600 Closed
CG
45
Cutler Group
California
– -$2K -600 Closed
Deutsche Bank
46
Deutsche Bank
Germany
– +$58 +9 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– +$135 +21 New
1
2

SMMT Hedge Fund Activity: Q1 2021 in Review

41 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q1 2021, worth a combined $54.6M — up 27% from $42.9M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SMMT positions and 6 closed out — a net gain of 4 holders — while 17 added to existing stakes and 8 trimmed.

The largest buyer was Polar Capital Holdings, adding an estimated $2.31M. The largest seller was JP Morgan Chase, cutting an estimated $3.03M.

  • 41 institutional investors held Summit Therapeutics (SMMT) as of Q1 2021, up from 37 in Q4 2020.
  • Funds reported $54.6M of Summit Therapeutics stock for Q1 2021, up 27% quarter-over-quarter.
  • 10 funds opened new Summit Therapeutics positions in Q1 2021 and 6 closed out, a net change of +4 holders.
  • The largest Summit Therapeutics buyer in Q1 2021 was Polar Capital Holdings, an estimated $2.31M added.
  • The largest Summit Therapeutics seller in Q1 2021 was JP Morgan Chase, an estimated $3.03M sold.

Based on aggregated 13F filings for Q1 2021.